Literature DB >> 23592268

A comparative study of short- and long-TE ¹H MRS at 3 T for in vivo detection of 2-hydroxyglutarate in brain tumors.

Changho Choi1, Sandeep Ganji, Keith Hulsey, Akshay Madan, Zoltan Kovacs, Ivan Dimitrov, Song Zhang, Kumar Pichumani, Dianne Mendelsohn, Bruce Mickey, Craig Malloy, Robert Bachoo, Ralph Deberardinis, Elizabeth Maher.   

Abstract

2-Hydroxyglutarate (2HG) is produced in gliomas with mutations of isocitrate dehydrogenase (IDH) 1 and 2. The (1) H resonances of the J-coupled spins of 2HG are extensively overlapped with signals from other metabolites. Here, we report a comparative study at 3 T of the utility of the point-resolved spectroscopy sequence with a standard short TE (35 ms) and a long TE (97 ms), which had been theoretically designed for the detection of the 2HG 2.25-ppm resonance. The performance of the methods is evaluated using data from phantoms, seven healthy volunteers and 22 subjects with IDH-mutated gliomas. The results indicate that TE = 97 ms provides higher detectability of 2HG than TE = 35 ms, and that this improved capability is gained when data are analyzed with basis spectra that include the effects of the volume localizing radiofrequency and gradient pulses.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  1H MRS; 2-hydroxyglutarate (2HG); 3 T; IDH-mutated gliomas; human brain; point-resolved spectroscopy (PRESS); short/long TE; volume-localized simulations

Mesh:

Substances:

Year:  2013        PMID: 23592268      PMCID: PMC3733061          DOI: 10.1002/nbm.2943

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  27 in total

1.  In vivo proton spectroscopy in presence of eddy currents.

Authors:  U Klose
Journal:  Magn Reson Med       Date:  1990-04       Impact factor: 4.668

2.  Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo.

Authors:  Janeta Popovici-Muller; Jeffrey O Saunders; Francesco G Salituro; Jeremy M Travins; Shunqi Yan; Fang Zhao; Stefan Gross; Lenny Dang; Katharine E Yen; Hua Yang; Kimberly S Straley; Shengfang Jin; Kaiko Kunii; Valeria R Fantin; Shunan Zhang; Qiongqun Pan; Derek Shi; Scott A Biller; Shinsan M Su
Journal:  ACS Med Chem Lett       Date:  2012-09-17       Impact factor: 4.345

3.  Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo.

Authors:  Isaac Marin-Valencia; Chendong Yang; Tomoyuki Mashimo; Steve Cho; Hyeonman Baek; Xiao-Li Yang; Kartik N Rajagopalan; Melissa Maddie; Vamsidhara Vemireddy; Zhenze Zhao; Ling Cai; Levi Good; Benjamin P Tu; Kimmo J Hatanpaa; Bruce E Mickey; José M Matés; Juan M Pascual; Elizabeth A Maher; Craig R Malloy; Ralph J Deberardinis; Robert M Bachoo
Journal:  Cell Metab       Date:  2012-06-06       Impact factor: 27.287

4.  Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas.

Authors:  Adam Elkhaled; Llewellyn E Jalbert; Joanna J Phillips; Hikari A I Yoshihara; Rupa Parvataneni; Radhika Srinivasan; Gabriela Bourne; Mitchel S Berger; Susan M Chang; Soonmee Cha; Sarah J Nelson
Journal:  Sci Transl Med       Date:  2012-01-11       Impact factor: 17.956

5.  Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy.

Authors:  Ovidiu C Andronesi; Grace S Kim; Elizabeth Gerstner; Tracy Batchelor; Aria A Tzika; Valeria R Fantin; Matthew G Vander Heiden; A Gregory Sorensen
Journal:  Sci Transl Med       Date:  2012-01-11       Impact factor: 17.956

6.  T2 measurement of J-coupled metabolites in the human brain at 3T.

Authors:  Sandeep K Ganji; Abhishek Banerjee; Aditya M Patel; Yan D Zhao; Ivan E Dimitrov; Jeffrey D Browning; E Sherwood Brown; Elizabeth A Maher; Changho Choi
Journal:  NMR Biomed       Date:  2011-08-15       Impact factor: 4.044

7.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.

Authors:  Lenny Dang; David W White; Stefan Gross; Bryson D Bennett; Mark A Bittinger; Edward M Driggers; Valeria R Fantin; Hyun Gyung Jang; Shengfang Jin; Marie C Keenan; Kevin M Marks; Robert M Prins; Patrick S Ward; Katharine E Yen; Linda M Liau; Joshua D Rabinowitz; Lewis C Cantley; Craig B Thompson; Matthew G Vander Heiden; Shinsan M Su
Journal:  Nature       Date:  2009-12-10       Impact factor: 49.962

8.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

9.  Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.

Authors:  Maria E Figueroa; Omar Abdel-Wahab; Chao Lu; Patrick S Ward; Jay Patel; Alan Shih; Yushan Li; Neha Bhagwat; Aparna Vasanthakumar; Hugo F Fernandez; Martin S Tallman; Zhuoxin Sun; Kristy Wolniak; Justine K Peeters; Wei Liu; Sung E Choe; Valeria R Fantin; Elisabeth Paietta; Bob Löwenberg; Jonathan D Licht; Lucy A Godley; Ruud Delwel; Peter J M Valk; Craig B Thompson; Ross L Levine; Ari Melnick
Journal:  Cancer Cell       Date:  2010-12-09       Impact factor: 38.585

10.  The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.

Authors:  Patrick S Ward; Jay Patel; David R Wise; Omar Abdel-Wahab; Bryson D Bennett; Hilary A Coller; Justin R Cross; Valeria R Fantin; Cyrus V Hedvat; Alexander E Perl; Joshua D Rabinowitz; Martin Carroll; Shinsan M Su; Kim A Sharp; Ross L Levine; Craig B Thompson
Journal:  Cancer Cell       Date:  2010-02-18       Impact factor: 38.585

View more
  36 in total

1.  In vivo detection of citrate in brain tumors by 1H magnetic resonance spectroscopy at 3T.

Authors:  Changho Choi; Sandeep K Ganji; Akshay Madan; Keith M Hulsey; Zhongxu An; Song Zhang; Marco C Pinho; Ralph J DeBerardinis; Robert M Bachoo; Elizabeth A Maher
Journal:  Magn Reson Med       Date:  2013-10-01       Impact factor: 4.668

2.  IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism.

Authors:  Jose L Izquierdo-Garcia; Pavithra Viswanath; Pia Eriksson; Larry Cai; Marina Radoul; Myriam M Chaumeil; Michael Blough; H Artee Luchman; Samuel Weiss; J Gregory Cairncross; Joanna J Phillips; Russell O Pieper; Sabrina M Ronen
Journal:  Cancer Res       Date:  2015-06-04       Impact factor: 12.701

3.  Reliable diagnosis of IDH-mutant glioblastoma by 2-hydroxyglutarate detection: a study by 3-T magnetic resonance spectroscopy.

Authors:  Manabu Natsumeda; Kunio Motohashi; Hironaka Igarashi; Takanori Nozawa; Hideaki Abe; Yoshihiro Tsukamoto; Ryosuke Ogura; Masayasu Okada; Tsutomu Kobayashi; Hiroshi Aoki; Hitoshi Takahashi; Akiyoshi Kakita; Kouichirou Okamoto; Tsutomu Nakada; Yukihiko Fujii
Journal:  Neurosurg Rev       Date:  2017-09-27       Impact factor: 3.042

Review 4.  From Krebs to clinic: glutamine metabolism to cancer therapy.

Authors:  Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2016-07-29       Impact factor: 60.716

Review 5.  Emerging applications of metabolomics in drug discovery and precision medicine.

Authors:  David S Wishart
Journal:  Nat Rev Drug Discov       Date:  2016-03-11       Impact factor: 84.694

6.  Diagnostic accuracy of 2-hydroxyglutarate magnetic resonance spectroscopy in newly diagnosed brain mass and suspected recurrent gliomas.

Authors:  Min Zhou; Yue Zhou; Huijun Liao; Benjamin C Rowland; Xiangquan Kong; Nils D Arvold; David A Reardon; Patrick Y Wen; Alexander P Lin; Raymond Y Huang
Journal:  Neuro Oncol       Date:  2018-08-02       Impact factor: 12.300

7.  Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics.

Authors:  Shanshan Jiang; Qihong Rui; Yu Wang; Hye-Young Heo; Tianyu Zou; Hao Yu; Yi Zhang; Xianlong Wang; Yongxing Du; Xinrui Wen; Fangyao Chen; Jihong Wang; Charles G Eberhart; Jinyuan Zhou; Zhibo Wen
Journal:  Eur Radiol       Date:  2017-12-12       Impact factor: 5.315

8.  Echo-planar spectroscopic imaging with dual-readout alternated gradients (DRAG-EPSI) at 7 T: Application for 2-hydroxyglutarate imaging in glioma patients.

Authors:  Zhongxu An; Vivek Tiwari; Sandeep K Ganji; Jeannie Baxter; Michael Levy; Marco C Pinho; Edward Pan; Elizabeth A Maher; Toral R Patel; Bruce E Mickey; Changho Choi
Journal:  Magn Reson Med       Date:  2017-08-22       Impact factor: 4.668

9.  Detection of 2-hydroxyglutarate in brain tumors by triple-refocusing MR spectroscopy at 3T in vivo.

Authors:  Zhongxu An; Sandeep K Ganji; Vivek Tiwari; Marco C Pinho; Toral Patel; Samuel Barnett; Edward Pan; Bruce E Mickey; Elizabeth A Maher; Changho Choi
Journal:  Magn Reson Med       Date:  2016-07-25       Impact factor: 4.668

10.  In vivo detection of 2-hydroxyglutarate in brain tumors by optimized point-resolved spectroscopy (PRESS) at 7T.

Authors:  Sandeep K Ganji; Zhongxu An; Vivek Tiwari; Sarah McNeil; Marco C Pinho; Edward Pan; Bruce E Mickey; Elizabeth A Maher; Changho Choi
Journal:  Magn Reson Med       Date:  2016-03-16       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.